Stabilization of c-KIT G-Quadruplex DNA structures by the RNA polymerase I inhibitors BMH-21 and BA-41

The stabilization of G-quadruplex DNA structures by small molecules with affinity to oncogene promoters has emerged as a promising anticancer strategy, due to a potential role in gene expression regulation. We explored the ability of BMH-21 (1) and its analogue BA-41 (2) to bind the G-quadruplex str...

ver descrição completa

Detalhes bibliográficos
Autores: Mazzini, Stefania, Gargallo Gómez, Raimundo, Musso, Loana, De Santis, Francesca, Aviñó Andrés, Anna, Scaglioni, Leonardo, Eritja i Casadellà, Ramon, Di Nicola, Massimo, Zunino, Franco, Amatulli, Annabella, Dallavalle, Sabrina
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/142066
Acesso em linha:https://hdl.handle.net/2445/142066
Access Level:acceso abierto
Palavra-chave:Ressonància magnètica nuclear
G-estructures
Nuclear magnetic resonance
G-structures
Descrição
Resumo:The stabilization of G-quadruplex DNA structures by small molecules with affinity to oncogene promoters has emerged as a promising anticancer strategy, due to a potential role in gene expression regulation. We explored the ability of BMH-21 (1) and its analogue BA-41 (2) to bind the G-quadruplex structure present in the c-KIT promoter by biophysical methods and molecular modeling. We provide evidence that both compounds interact with the c-KIT 21-mer sequence. The stable monomeric intramolecular parallel G-quadruplex obtained by the mutation of positions 12 and 21 allowed the precise determination of the binding mode by NMR and molecular dynamics studies. Both compounds form a complex characterized by one ligand molecule positioned over the tetrad at the 30-end, stabilized by an extensive network of pi-pi interactions. The binding constants (Kb) obtained with fluorescence are similar for both complexes (around 10^6 M-1). Compound BA-41 (2) showed significant antiproliferative activity against a human lymphoma cell line, SU-DHL4, known to express substantial levels of c-KIT. However, the partial inhibition of c-KIT expression by Western blot analysis suggested that the interaction of compound 2 with the c-KIT promoter is not the primary event and that multiple e ects provide a contribution as determinants of biological activity.